Alefacept
Top View
- Articles Targeting of Memory T Cells with Alefacept in New-Onset Type 1 Diabetes (T1DAL Study): 12 Month Results of a Randomised
- Biological Therapies in Psoriasis - Revisited
- Drug Class Review Targeted Immune Modulators
- Recent Topics on the Mechanisms of Immunosuppressive Therapy-Related Neurotoxicities
- World Journal of Transplantation
- Alefacept for Severe Alopecia Areata a Randomized, Double-Blind, Placebo-Controlled Study
- COMPARISON of the WHO ATC CLASSIFICATION & Ephmra/Intellus Worldwide ANATOMICAL CLASSIFICATION
- 2019 Table of Drugs
- Subject Index
- Amevive (Alefacept)
- Alefacept in the Treatment of Recalcitrant Palmoplantar and Erythrodermic Psoriasis
- New Immunosuppression Horizons in Kidney Transplantation
- Alefacept for Psoriasis Michael P
- Alefacept Boosts Response to Methotrexate in Patients with Psoriatic Arthritis
- Alefacept Provides Sustained Clinical and Immunological Effects in New-Onset Type 1 Diabetes Patients
- Impact of Immune-Modulatory Drugs on Tregs Akiko Furukawa, MD, Steven A. Wisel, MD, and Qizhi Tang, Phd Department of Surgery, U
- Systemic Pharmacological Treatments for Chronic Plaque Psoriasis : a Network Meta-Analysis
- Statistical Analysis Plan Version 3